Controlled Drug Delivery Systems: Current Status and Future Directions

被引:858
作者
Adepu, Shivakalyani [1 ]
Ramakrishna, Seeram [1 ]
机构
[1] Natl Univ Singapore NUS, Ctr Nanofibers & Nanotechnol, 21 Lower Kent Ridge Rd, Singapore 119077, Singapore
关键词
controlled release dosage forms; pharmacokinetics; nano-drug delivery; smart and stimuli-responsive delivery; intelligent biomaterials; MESOPOROUS SILICA NANOPARTICLES; CARBON NANOTUBES; BACTERIAL CELLULOSE; SUSTAINED-RELEASE; QUANTUM DOTS; ABSORPTION; CARRIERS; MICROSPHERES; NANOCARRIERS; FORMULATION;
D O I
10.3390/molecules26195905
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The drug delivery system enables the release of the active pharmaceutical ingredient to achieve a desired therapeutic response. Conventional drug delivery systems (tablets, capsules, syrups, ointments, etc.) suffer from poor bioavailability and fluctuations in plasma drug level and are unable to achieve sustained release. Without an efficient delivery mechanism, the whole therapeutic process can be rendered useless. Moreover, the drug has to be delivered at a specified controlled rate and at the target site as precisely as possible to achieve maximum efficacy and safety. Controlled drug delivery systems are developed to combat the problems associated with conventional drug delivery. There has been a tremendous evolution in controlled drug delivery systems from the past two decades ranging from macro scale and nano scale to intelligent targeted delivery. The initial part of this review provides a basic understanding of drug delivery systems with an emphasis on the pharmacokinetics of the drug. It also discusses the conventional drug delivery systems and their limitations. Further, controlled drug delivery systems are discussed in detail with the design considerations, classifications and drawings. In addition, nano-drug delivery, targeted and smart drug delivery using stimuli-responsive and intelligent biomaterials is discussed with recent key findings. The paper concludes with the challenges faced and future directions in controlled drug delivery.</p>
引用
收藏
页数:45
相关论文
共 177 条
[1]  
Adeosun S.O., 2020, Advanced Functional Materials, DOI DOI 10.5772/INTECHOPEN.93368
[2]  
Adepu S., 2021, T INDIAN NATL ACAD E, V6, P265, DOI [10.1007/s41403-020-00192-w, DOI 10.1007/S41403-020-00192-W]
[3]   Drug release behaviour and mechanism from unmodified and in situ modified bacterial cellulose [J].
Adepu, Shivakalyani ;
Khandelwal, Mudrika .
PROCEEDINGS OF THE INDIAN NATIONAL SCIENCE ACADEMY, 2021, 87 (01) :110-120
[4]   Heparin-Tagged PLA-PEG Copolymer-Encapsulated Biochanin A-Loaded (Mg/Al) LDH Nanoparticles Recommended for Non-Thrombogenic and Anti-Proliferative Stent Coating [J].
Adepu, Shivakalyani ;
Luo, Hongrong ;
Ramakrishna, Seeram .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (11)
[5]   Ex-situ modification of bacterial cellulose for immediate and sustained drug release with insights into release mechanism [J].
Adepu, Shivakalyani ;
Khandelwal, Mudrika .
CARBOHYDRATE POLYMERS, 2020, 249
[6]   Bacterial cellulose with microencapsulated antifungal essential oils: A novel double barrier release system [J].
Adepu, Shivakalyani ;
Khandelwal, Mudrika .
MATERIALIA, 2020, 9
[7]   Broad-spectrum antimicrobial activity of bacterial cellulose silver nanocomposites with sustained release [J].
Adepu, Shivakalyani ;
Khandelwal, Mudrika .
JOURNAL OF MATERIALS SCIENCE, 2018, 53 (03) :1596-1609
[8]   Effect of micropatterning induced surface hydrophobicity on drug release from electrospun cellulose acetate nanofibers [J].
Adepu, Shivakalyani ;
Gaydhane, Mrunalini K. ;
Kakunuri, Manohar ;
Sharma, Chandra S. ;
Khandelwal, Mudrika ;
Eichhorn, Stephen J. .
APPLIED SURFACE SCIENCE, 2017, 426 :755-762
[9]   Exosomes: Structure, Biogenesis, Types and Application in Diagnosis and Gene and Drug Delivery [J].
Agarwal, Shriya ;
Agarwal, Vinayak ;
Agarwal, Mugdha ;
Singh, Manisha .
CURRENT GENE THERAPY, 2020, 20 (03) :195-206
[10]   Transdermal patches: Design and current approaches to painless drug delivery [J].
Al Hanbali, Othman A. ;
Khan, Haji Muhammad Shoaib ;
Sarfraz, Muhammad ;
Arafat, Mosab ;
Ijaz, Shakeel ;
Hameed, Abdul .
ACTA PHARMACEUTICA, 2019, 69 (02) :197-215